Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07364981 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gaze Contingent Attentional Reinforcement in Major Depressive Disorder

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Tel Aviv University
26 trials monitored
See 2 trials at risk
Depression
3,055 trials monitored
See 173 trials at risk
The main objective of this randomized controlled trial is to evaluate whether a gaze-contingent feedback task using negative reinforcement can serve as an effective attention-modification procedure and contribute to the treatment of Major Depressive Disorder (MDD).
Trial Details
NCT Number NCT07364981
Lead Sponsor Tel Aviv University
Conditions
(from sponsor)		 Major Depressive Disorder (MDD)
Related terms Major Depressive Disorder
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov